Michael Tesfaldet T, Mogabgab Owen, Alomar Mohammed, Kotsia Anna, Christopoulos George, Rangan Bavana V, Abdullah Shuaib, Grodin Jerrold, Banerjee Subhash, Brilakis Emmanouil S
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
J Interv Cardiol. 2014 Oct;27(5):465-71. doi: 10.1111/joic.12149. Epub 2014 Aug 26.
To compare long-term clinical outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) using the retrograde and antegrade approach.
There is limited long-term clinical outcomes data on the retrograde approach to CTO PCI.
We performed a retrospective analysis of the long-term clinical outcomes of 193 consecutive patients who underwent successful CTO PCI at our institution between March 2008 and December 2011.
Mean age was 63.6 ± 8.3 years. The target vessel was right coronary artery in 52.6%, left anterior descending artery in 24.5% and circumflex in 21.4% of cases. The retrograde approach was used in 41 patients (21.2%). The mean stent length was longer in the retrograde group (83 ± 32 vs. 64 ± 32 mm, P = 0.001). Two major procedural complications occurred, both in the retrograde group (P = 0.012). During a median follow-up of 2.0 years compared to the antegrade CTO PCI group, patients who underwent retrograde CTO PCI were more likely to undergo target lesion revascularization (TLR) (45.6% vs. 25.7%, P = 0.006). No significant difference was observed in the incidence of all-cause mortality, myocardial infarction, non-target vessel revascularization, or coronary artery bypass graft surgery between the 2 groups. On multivariate analysis, stent length was the only independent predictor of TLR during follow-up.
Retrograde CTO PCI was associated with higher incidence of TLR, but similar incidence of death and myocardial infarction compared to antegrade CTO PCI. These findings likely reflect the higher complexity of CTO lesions treated with the retrograde approach.
比较采用逆行和顺行入路进行慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的长期临床结果。
关于CTO PCI逆行入路的长期临床结果数据有限。
我们对2008年3月至2011年12月期间在本机构连续接受成功CTO PCI的193例患者的长期临床结果进行了回顾性分析。
平均年龄为63.6±8.3岁。52.6%的病例靶血管为右冠状动脉,24.5%为左前降支,21.4%为回旋支。41例患者(21.2%)采用逆行入路。逆行组的平均支架长度更长(83±32 vs. 64±32 mm,P = 0.001)。发生了2例主要手术并发症,均在逆行组(P = 0.012)。与顺行CTO PCI组相比,在中位随访2.0年期间,接受逆行CTO PCI的患者更有可能接受靶病变血运重建(TLR)(45.6% vs. 25.7%,P = 0.006)。两组在全因死亡率、心肌梗死、非靶血管血运重建或冠状动脉旁路移植术的发生率方面未观察到显著差异。多因素分析显示,支架长度是随访期间TLR的唯一独立预测因素。
与顺行CTO PCI相比,逆行CTO PCI的TLR发生率较高,但死亡和心肌梗死发生率相似。这些发现可能反映了采用逆行入路治疗的CTO病变具有更高的复杂性。